Adams Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$394K Sell
328
-1
-0.3% -$1.02K 0.08% 119
2026
Q1
$303K Hold
329
0.07% 125
2025
Q4
$354K Sell
329
-6
-2% -$5.74K 0.08% 117
2025
Q3
$256K Hold
335
0.05% 155
2025
Q2
$261K Hold
335
0.05% 144
2025
Q1
$277K Sell
335
-15
-4% -$12.5K 0.05% 110
2024
Q4
$271K Sell
350
-104
-23% -$86.1K 0.05% 104
2024
Q3
$403K Buy
454
+45
+11% +$40.5K 0.09% 91
2024
Q2
$371K Buy
409
+60
+17% +$48K 0.09% 91
2024
Q1
$272K Hold
349
0.07% 95
2023
Q4
$204K Buy
+349
New +$204K 0.06% 93
2020
Q4
Sell
-366
Closed -$54K 218
2020
Q3
$54K Buy
+366
New +$56.6K 0.04% 106

Other funds holding LLY

Adams Wealth Management's LLY Position: Q2 2026 in Review

Adams Wealth Management reduced its Eli Lilly (LLY) stake by 0.3% in Q2 2026, selling an estimated $1.02K and leaving 328 shares worth $394K. The position accounts for 0.08% of the portfolio, ranked #119.

Adams Wealth Management first reported a position in LLY in Q3 2020 and has held it in 12 quarters since. The position peaked at $403K in Q3 2024. 4,633 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Adams Wealth Management held 328 shares of Eli Lilly worth $394K as of Q2 2026.
  • Adams Wealth Management sold 1 Eli Lilly share in Q2 2026, an estimated $1.02K.
  • Eli Lilly made up 0.08% of Adams Wealth Management's portfolio in Q2 2026, its #119 holding.
  • Adams Wealth Management first reported a position in Eli Lilly in Q3 2020 and has held it in 12 quarters since.
  • Adams Wealth Management's Eli Lilly position peaked at $403K in Q3 2024.
  • 4,633 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Adams Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.